Task: Answer the MCQ question.
Query: Which drug exhibits a 7.044\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) Cn1c(SCC(=O)N/N=C/c2ccc(O)c(O)c2)nc2ccccc21
b) COC(=O)c1c(NC(=O)Cc2ccccc2)sc2c1CC(C)(C)NC2(C)C
c) CCCOc1ccc(N2C(=O)CC(N(Cc3ccco3)C(C)=O)C2=O)cc1
Answer: a. Cn1c(SCC(=O)N/N=C/c2ccc(O)c(O)c2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)N/N=C/c2ccc(O)c(O)c2)nc2ccccc21
Cn1c(SCC(=O)N/N=C/c2ccc(O)c(O)c2)nc2ccccc21
N-[(E)-(3,4-dihydroxyphenyl)methylideneamino]-2-(1-methylbenzimidazol-2-yl)sulfanylacetamide